Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-31.02%
↑ 86% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-220.40%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -31.02% |
| 2024 | -133.31% |
| 2023 | -717.27% |
| 2022 | 0.00% |